AstraZeneca Market Cap

AstraZeneca has a market cap or net worth of $246.42 billion as of October 12, 2026. Its market cap has decreased by 5.96% in one year.

Market Cap

246.42B

Enterprise Value

273.76B

1-Year Change

-5.96%

Global Rank

n/a

Country Rank

n/a

ChartMarket Cap Chart

Chart

Since November 21, 2000, AstraZeneca's market cap has increased from $126.35B to $246.42B, an increase of 95.03%. That is a compound annual growth rate of 2.61%.

Market Cap History

Date	Market Cap	% Change
Oct 12, 2026	246.42B	-13.53%
Dec 31, 2025	284.98B	40.31%
Dec 31, 2024	203.11B	-2.65%
Dec 29, 2023	208.65B	-0.60%
Dec 30, 2022	209.91B	20.44%
Dec 31, 2021	174.28B	32.86%
Dec 31, 2020	131.17B	1.42%
Dec 31, 2019	129.34B	34.47%
Dec 31, 2018	96.18B	9.54%
Dec 29, 2017	87.81B	27.12%
Dec 30, 2016	69.07B	-19.47%
Dec 31, 2015	85.77B	-3.07%
Dec 31, 2014	88.48B	19.53%
Dec 31, 2013	74.02B	21.17%
Dec 31, 2012	61.09B	-6.34%
Dec 30, 2011	65.22B	-2.68%
Dec 31, 2010	67.02B	-1.37%
Dec 31, 2009	67.95B	13.67%
Dec 31, 2008	59.78B	-7.97%
Dec 31, 2007	64.96B	-23.07%
Dec 29, 2006	84.44B	6.23%
Dec 30, 2005	79.49B	29.74%
Dec 31, 2004	61.26B	-26.15%
Dec 31, 2003	82.95B	37.87%
Dec 31, 2002	60.17B	-55.10%

View and export this data all the way back to 2000. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Related Stocks

Company	Market Cap
Johnson & Johnson	630.04B
AbbVie	488.55B
Merck & Co.	359.22B
Novartis AG	272.48B
Amgen	224.29B
Gilead Sciences	187.44B
Novo Nordisk	169.11B
Pfizer	161.19B

Market Cap Rankings